Ignite Creation Date:
2024-05-05 @ 11:08 AM
Last Modification Date:
2024-10-26 @ 9:05 AM
Study NCT ID:
NCT00006489
Status:
COMPLETED
Last Update Posted:
2017-04-21
First Post:
2000-11-08
Brief Title:
Treatment for Alcoholism and Post-Traumatic Stress Disorder Naltrexone
Sponsor:
University of Pennsylvania
Organization:
University of Pennsylvania
Study Overview
Official Title:
Naltrexone and Cognitive-Behavioral Therapy for Patients With Alcoholism and Post-Traumatic Stress Disorder
Status:
COMPLETED
Status Verified Date:
2017-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will evaluate naltrexone and cognitive-behavioral therapy treatments for alcohol dependence and post-traumatic stress disorder PTSD Subjects will be randomly assigned a 6-month treatment of either 1 naltrexone alone 2 naltrexone with PTSD psychosocial therapy 3 a placebo with PTSD psychosocial therapy or 4 placebo alone An enhanced medication management intervention will accompany all treatment conditions Follow-up assessments will be completed at 9 and 12 months after treatment
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NIH grant R01-AA-012428 | US NIH GrantContract | None | httpsreporternihgovquickSearchR01AA012428 |
| R01AA012428 | NIH | None | None |